Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

Market Cap	3.42B
Revenue (ttm)	1.95B
Net Income (ttm)	62.44M
Shares Out	534.07M
EPS (ttm)	0.12
PE Ratio	56.44
Forward PE	n/a
Dividend	0.15 (2.23%)
Ex-Dividend Date	Jun 5, 2025

Volume	5,314,501
Average Volume	8,114,049
Open	6.73
Previous Close	6.72
Day's Range	6.62 - 6.75
52-Week Range	5.03 - 8.87
Beta	0.57
RSI	59.25
Earnings Date	Aug 30, 2025

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, nourishing and soothing, tonic products, cold and cough, children's medicine, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1990
• Employees: 1,266
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600613

Financial Performance

In 2024, SHA:600613's revenue was 2.05 billion, a decrease of -12.48% compared to the previous year's 2.34 billion. Earnings were 71.39 million, an increase of 25.24%.